Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

A phase II multicenter prospective study to evaluate the safety and efficacy of myeloablative-dose treosulfan plus fludarabine (FT14) conditioning regimen in allogeneic hematopoietic stem cell transplantation for AML patients aged 40–65 in first complete remission

Title:	A phase II multicenter prospective study to evaluate the safety and efficacy of myeloablative-dose treosulfan plus fludarabine (FT14) conditioning regimen in allogeneic hematopoietic stem cell transplantation for AML patients aged 40–65 in first complete remission
Authors:	Avenoso, Daniele^Aff1; Radici, Vera^Aff1; Leoni, Alessandro^Aff1; Skert, Cristina^Aff2; Martino, Massimo^Aff3; Mordini, Nicola^Aff4; Saraceni, Francesco^Aff5; Olivieri, Attilio^Aff5; Ciceri, Fabio^Aff6; Tecchio, Cristina^Aff7; Picardi, Alessandra^Aff8; Saporiti, Giorgia^Aff9; Patriarca, Francesca^Aff10; Bresciani, Paola^Aff11; Nozzoli, Chiara^Aff12; Maravalle, Denise^Aff13; Polverelli, Nicola^Aff14; Magliano, Gabriele^Aff1; Morello, Enrico^Aff1; Farina, Mirko^Aff1; Bernardi, Simona^Aff1; Re, Federica^Aff1; Garuffo, Luca^Aff1; Maifredi, Simone^Aff1; Zanon, Silvia^Aff1; De Domenico, Rachele^Aff1; Malagola, Michele^Aff1; Russo, Domenico^{Aff1, IDs41409026029377_cor1}
Source:	Bone Marrow Transplantation: Official journal of the European Society for Blood and Marrow Transplantation. :1-6
Database:	Springer Nature Journals